|
S.L. Babak, M.V. Gorbunova, A.G. Malyavin
New strategy of mucolytic therapy in modern medical practice
|
№1 / 2018
|
|
S.N. Avdeev, Z.R. Aysanov, A.S. Belevsky
Сlinical guidelines of Russian respiratory society: algorithm for the management of patients with chronic obstructive pulmonary disease
|
№4 / 2017
|
|
M.A. Karnaushkina, S.V. Fedosenko, V.A. Petrov, A.G. Malyavin, A.D. Strutynskaya, N.A. Cherkasova, L.M. Ogorodova
Metagenomic analysis of oropharyngeal microbiota in patients with different phenotypes of chronic obstructive pulmonary disease
|
№1 / 2017
|
|
L.I. Dvoretsky, Ye.V. Sergeeva
Antibacterial therapy of copd exacerbations: prescribe or not prescribe
|
№1 / 2017
|
|
Ye.I. Samorukova, T.V. Adasheva, S.V. Pavlov
Correction of systemic inflammation, oxidative stress and antioxidant defense using rosuvastatin in patients with chronic obstructive pulmonary disease
|
№1 / 2017
|
|
N.T. Vatutin, A.S. Smirnova, Ye.S. Gasendich
The evaluation of lipid profile in patients with chronic heart failure and concomitant chronic obstructive pulmonary disease
|
№6 / 2016
|
|
K.I. Tebloev, K.A. Fomina, Ye.V. Zhilyaev, A.A. Spassky
Evaluation of the influence of various factors on progression of chronic obstructive pulmonary disease and bronchial asthma: results of long-term cohort study
|
№5 / 2016
|
|
N.A. Karoli, A.P. Rebrov
Some aspects of pathogenesis and prevention of sudden cardiac death in patients with chronic obstructive pulmonary disease
|
№4 / 2016
|
|
N.Yu. Grigorieva, A.N. Kuznetsov
Arterial hypertension and chronic bronchopulmonary diseases
|
№3 / 2016
|
|
A.V. Budnevsky, B.B. Romashov, N.V. Polyakova, Ye.Yu. Malysh
Actual issues of pathogenesis, clinic and treatment of chronic obstructive pulmonary disease and diabetes
|
№1 / 2016
|
|
A.A. Zaitsev, Ye.V. Kryukov
Modes of antimicrobial therapy and prevention of exacerbations of chronic bronchitis/chronic obstructive pulmonary disease
|
№1 / 2016
|
Русский
